Acasti Pharma
ACST
$2.78
Share price
3.73%
Change (1 day)
504.35%
Change (1 year)
Categories
Acasti Pharma (ACST) - Cash on Hand
Cash on Hand as of December 2023 : $25.11 M
According to Acasti Pharma
's latest financial reports the company has $25.11 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Acasti Pharma - Cash on Hand chart (from 2020 to 2019)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-03-31 | $27.89 M | -36.12% |
| 2022-03-31 | $43.66 M | -28.11% |
| 2021-03-31 | $60.73 M | 326.48% |
| 2020-03-31 | $14.24 M | -26.22% |
| 2019-03-31 | $19.29 M | 290.78% |
| 2018-03-31 | $4.93 M | |
| 2016-02-29 | $5.7 M | |
| 2015-02-28 | $11.73 M | -38.7% |
| 2014-02-28 | $19.15 M | 319.36% |
| 2013-02-28 | $4.56 M | |
| 2012-02-29 | $7.21 M | |
| 2011-02-28 | $2.95 M | 661.16% |
| 2010-02-28 | $0.38 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Omeros Corporation OMER | $0.31 B | 1,135.61% | 🇺🇸 USA |